Objective: To explore the potential contribution of respiratory infections and vitamin A intakes to the seasonal effect of vitamin A supplementation on child growth. Methods: Data from a randomized double-blind placebo-controlled trial, in which a single high dose of vitamin A or placebo was given every 4 months to 1405 children aged 6-48 months were used for the analysis. In total, 4430 child-treatment cycles were examined, and for each cycle the children had their dietary intake, weight, and height assessed at the start and end. Linear regression models of the difference in height and weight during each treatment cycle were used and the within-child correlation was adjusted using the generalized estimating equations (GEE). Other covariables in the model included age, sex, percentage of days with acute lower respiratory infection and diarrhea, and cumulative doses of vitamin A. Results: This study showed that a significant effect of vitamin A supplementation on linear growth was observed in all seasons in children with a low burden of respiratory infections, that is, o21.5% of days with respiratory illness. In each season, the highest effect was found in children with a low burden of respiratory infections and low vitamin A intakes, that is, intakes o400 RE/day. Children with a high burden of respiratory infections or high vitamin A intakes benefited less from vitamin A supplementation for their linear growth than children with a low burden of respiratory infections and low vitamin A intakes. Finally, there was no benefit for linear growth from vitamin A supplementation in children with both a high burden of respiratory infections and high vitamin A intakes regardless of the season. Conclusions: The effect of vitamin A supplementation on growth is dependent on season. Respiratory infections and vitamin A intakes are important factors underlying the seasonal effect of vitamin A supplementation on growth.
Introduction
Studies on the effect of vitamin A on growth around the world have yielded conflicting results; some have reported no effect (Lie et al, 1993; Ramakrishnan et al, 1995) , while others have reported a positive effect of vitamin A supplementation on growth (Arroyave et al, 1979; Muhilal et al, 1988; West et al, 1988) . Among those articles reporting a positive effect, some noted that the effect was greater in children Z2 y (Muhilal et al, 1988; Hadi et al, 2000) , and in non-breastfed children (Hadi et al, 2000) . Furthermore, the positive effect of vitamin A supplementation on growth was restricted to children with low serum retinol concentrations (Hadi et al, 2000) or children with xerophthalmia (West et al, 1997) , and was only observed in summer (Bahl et al, 1997) or the late dry season (West et al, 1997) . The strongest effect was found in the late dry season (Hadi et al, 2002) , while the least effect (Hadi et al, 2002) or a slightly negative effect (West et al, 1997) of vitamin A supplementation on growth was found during winter.
Part of the biological mechanism behind the age-specific effect of vitamin A supplementation on growth can be explained by the presence of breastfeeding (Hadi et al, 2000) . Non-breastfed children benefit more in height from vitamin A than breastfed children regardless of their age (Hadi et al, 2000) . Thus, breastfeeding might protect children from vitamin A deficiency (West et al, 1986) and maintain their vitamin A status at normal levels, such that breastfed children respond less to vitamin A supplementation than nonbreastfed children (Hadi et al, 2000) . The biological mechanism behind the seasonal effect of vitamin A on growth is less clear than that of the age-specific effect. However, there is a suggestion that vitamin A intakes and burden of infectious diseases, especially respiratory infections, are responsible for the biological mechanism behind this seasonal effect. The potential mechanism can be explained as follows. First, vitamin A intakes (Schaefer, 1981; Hadi et al, 2002) and xerophthalmia (Sinha & Bang, 1973 , 1976 in developing countries vary by season. Second, the distribution of infectious diseases, especially diarrhea and respiratory infections, also vary by season (Hadi et al, 2002) . Third, respiratory infections, especially those with elevated body temperature, have been found to be associated with higher rates of urinary retinol excretion (Stephensen et al, 1994) , and reduce the growth response to vitamin A supplementation (Hadi et al, 1999) . Lastly, the effect of vitamin A supplementation on growth is highest in children with low vitamin A intakes and a low burden of respiratory infections (Hadi et al, 1999) . This analysis was conducted using data from a randomized placebo-controlled trial of Javanese preschool children to examine whether the levels of respiratory infections and vitamin A intakes are the potential explanations for seasonal effects of vitamin A supplementation on child growth.
Subjects and methods

Study population and design
Data used in the analysis were obtained from the MORVITA trial, a collaborative research project implemented by the Johns Hopkins University, Baltimore, USA, and the Faculty of Medicine, University of Gadjah Mada between 1989 and 1992. Details of the study design and the effect of vitamin A supplementation on infectious diseases are described elsewhere (Dibley et al, 1996) , but important aspects of the trial methods are summarized below.
The trial was located in 34 villages from Purworejo, a rural district on the southern coast of Central Java. The total population of these villages was approximately 20 000 and they were predominately farmers with rice, seasonal vegetables and fruits dominating the major crops and their dietary intake patterns. In these communities a randomized, double-masked, placebo-controlled trial was conducted in which the treatments were given once every 4 months for six treatment cycles. There were 4693 child-treatment cycles but only 4437 had complete weight pairs and 4430 had complete height and weight pairs (Table 1) . Therefore, analysis was conducted using those child-treatment cycles where the subjects had both height and weight increments; 2178 from the placebo group and 2252 from the vitamin A group. These 4430 child-treatment cycles came from 1324 children, of which 240 children contributed one treatment cycle, 237 children contributed two treatment cycles, 318 children contributed three treatment cycles, 124 children contributed four treatment cycles, 164 children contributed five treatment cycles, and 241 children contributed six treatment cycles of the total child-treatment cycles used in this Although the hypotheses examining the impact of vitamin A on growth were secondary hypotheses in the Morvita trial, these research questions were planned to be examined from the beginning of the trial. Data were collected in the trial to allow the investigators to examine these specific hypotheses adequately. These hypotheses about vitamin A and child growth are independent of those that relate to the effects of vitamin A on childhood morbidity.
Data collection procedures
Anthropometric data. A team of trained anthropometrists measured the child's weight and height at regular intervals. Weight was measured every month in the integrated village health services post, while recumbent length or standing height was measured only every 4 months at the start of each cycle at the trial examination clinics. If the child did not attend the post or clinic, the anthropometric team measured their weight and height at home.
Morbidity data. Trained interviewers, who visited the children and their guardians every other day at home, assessed the child's morbidity experience by recording symptoms of diarrhea and respiratory illnesses. If the child was absent, the interview was attempted at the next scheduled home visit. The longest recall period allowed was 4 days. These morbidity data were collected using Javanese language, on standardized precoded forms, which had been developed by an anthropologist using focus group discussions and in-depth interviews with village women prior to the data collection.
Episodes of diarrhea were defined as adjoining days for which the child was reported to have three or more loose stools per 24-h period and ended if there were two or more symptom-free or missing data days. Episodes of acute respiratory illness (ARI) were defined as two or more adjoining days for which the child was reported to have cough and ended if there were three or more symptom-free or missing data days. Episodes of acute lower respiratory illness (ALRI) were defined as periods of two or more adjoining days for which the child was reported to have cough and during which there was at least one elevated respiratory rate measurement, that is, 50 respirations per minute for all groups. The percentage of days with ARI was defined as the total observed days with ARI divided by the total days of observation multiplied by 100. Similar formulae were used to define the percentage of days with diarrhea and the percentage of days with ALRI.
Assessment of vitamin A status. Vitamin A status was assessed at the start of each child's first treatment cycle using serum retinol as the measurement. High-performance liquid chromatography (HPLC) was used for laboratory analysis. Blood samples were collected from the children by antecubital venipuncture into a capped colored glass tube and transported on ice to the field office where they were centrifuged and aliquoted. On the same day sera were transported on ice to the laboratory where HPLC procedures were carried out.
Dietary Vitamin A intake. A food frequency questionnaire was used to characterize the habitual vitamin A intake of individual children. A 1-month recall period was used because the diets of young children change rapidly and because of the seasonal availability of many foods in the study area. The food frequency questionnaire was completed by high school graduates who were trained and supervised by nutritionists. These supervisors were also responsible for field editing of dietary intake forms. Interviews were conducted on the same day or within 2 days of the child's treatment cycle except for the first cycle where 30% of the interviews were conducted about 1 month after the trial examination clinic.
Data management and statistical analysis
Precoded forms with preprinted identification labels were used for data collection. Data forms were edited by field supervisors before data entry and then entered into computers by trained operators using dSurvey software (Corner, 1989) . Statistical analyses were completed using STATA 5.0 software. Anthropometric indicators were calculated using the World Health Organization international growth
Complex interactions with infection and diet H Hadi et al reference (Dibley et al, 1987) , which is available in the Epi Info 2000 software (Dean et al, 2000) . As most children contributed more than one treatment cycle to the analysis, generalized estimating equations (GEE) were used in the analysis to account for the correlation of the repeated responses within individuals, and to allow full use of data from all 4430 child treatment cycles.
The outcome variable of this analysis was the 4-month height or weight increment. The explanatory variables included treatment, age, sex, percentage of days of ARI, percentage of days of diarrhea, dietary vitamin A intake, initial nutritional status, and season. Since children received different age-specific doses of vitamin A over the course of the study, all models in this analysis were adjusted for the cumulative dose of vitamin A in international units. This cumulative dose reflected the total dose of vitamin A that had been received by each individual prior to a cycle-specific treatment. The trial treatment was handled as a categorical variable: vitamin A or placebo. Age was grouped into four categories and treated as three dummy variables; 6-18; 19-30; 31-42; and Z43 months. Vitamin A intake was handled as a dichotomous variable: below or above the normative requirement (4400 RE/day). Percentage of days with respiratory infection was treated as a dichotomous variable; o21.5 or Z 21.5%. The cutoff of 21.5% of days with respiratory infection was used because it was the 75th percentile of that distribution and because there was no difference in the growth response to vitamin A at lower levels (Hadi et al, 1999) . Children with respiratory infections o21.5% of the observed time were then considered to have a low burden, while children with respiratory infections Z 21.5% of the observed time were considered to have a high burden of respiratory infections. The percentage of days with diarrhea was treated as a continuous variable. Season was grouped into three different seasons and handled as two dummy variables: season 1 (December-March), season 2 (April-July), and season 3 (August-November). To test whether season (SE), in combination with respiratory infection (RI) modified the effect of vitamin A supplementation, children were stratified into three different seasons (SE 1 ¼ season 1 , SE 2 ¼ season 2 , and SE 3 ¼ season 3 ) and two levels of respiratory infections (RI 0 ¼ below or RI 1 ¼ above 21.5% of days with respiratory infections). This stratification resulted in six different combinations of respiratory infections and seasons. This new variable (termed SERI) was treated as five dummy variables and included in the model with their corresponding interaction terms with treatment.
To test whether season (SE) in combination with respiratory infection (RI) and vitamin A (VA) intake modified the effect of vitamin A supplementation, children were stratified into three different seasons (SE 1 ¼ season 1 , SE 2 ¼ season 2 , and SE 3 ¼ season 3 ), two levels of respiratory infections (RI 0 ¼ below 21.5% or RI 1 ¼ above 21.5% of reparatory infections) and two levels of vitamin A intakes (VA 0 ¼ below or VA 1 ¼ above normative requirements, that is 400 RE/day). This stratification resulted in 12 different combinations of seasons, respiratory infections, and vitamin A intake. This new variable (termed SERIVA) was treated as 11 dummy variables and included in the model with their corresponding interaction terms with treatment. Both the main effect and the treatment interactions of the explanatory variables were considered. The goodness of fit of the GEE was tested using the Scale parameter, Pearson w 2 and dispersion (Pearson) tests.
Results
Characteristics of the treatment groups
The two treatment groups of the study participants used in this analysis had similar distributions in terms of demographic and nutritional characteristics at their start treatment cycle ( Table 2 ). The study population was characterized by a high prevalence of subclinical vitamin A deficiency, with 51.6% having a serum retinol of 0.35-0.70 mmol/ l and 15.9% with serum retinol of o0.35 mmol/ l. However, only one child with a Bitot's spot had any evidence of clinical vitamin A deficiency. About 29.4% of the study subjects had vitamin A intake less than the basal requirement and 32% of them were stunted.
Seasonal variation of vitamin A intakes, percentage of days with ARI, ALRI and diarrhea
Vitamin A intakes of this study population varied by season (Table 3) . About 22% percent of children had vitamin A intakes less than the basal requirement (o200 RE/day) in season 1 and season 2 . The proportion of children with vitamin A intakes o200 RE/day was 5.5% higher in season 3 in comparison to that in season 1 and season 2 . Conversely, the proportion of children with vitamin A intake more than normative requirement (4400 RE/day) was lower in season 3 in comparison to that in season 1 and season 2 . The percentage of days with ARI, ALRI and diarrhea was also different by season (Table 3 ). In brief, the proportion of children with no days of ARI, ALRI, or diarrhea was higher in season 3 in comparison to that in season 1 and season 2 . Conversely, the proportion of children with more days of ARI, ALRI, and diarrhea was lower in season 3 in comparison to that in season 1 and season 2 .
Effect of vitamin A on growth by season and respiratory infections
In this analysis, there was no significant difference in the height increment when children were stratified by season and burden of respiratory infections (SERI, Figure 1 ). However, the effect of vitamin A supplementation on linear growth was modified by SERI. In season 1 , children with respiratory infections for Z 21.5% of the total days of observation (SE 1 RI 1 ), receiving vitamin A, grew 0.118 cm/4 months less in height than children receiving placebo, but In season 2 , the height increment of children with respiratory infections o21.5% of the time (SE 2 RI 0 ) receiving vitamin A was 0.137 cm/4 months (ie, 0.255-0.118) higher (Po0.05) than that of their peers receiving placebo in the same season, while the height increment of children with respiratory infections Z21.5% of the time during season 2 (SE 2 RI 1 ) receiving vitamin A was only 0.027 cm/4 months (ie, 0.145-0.118) higher than that of their peers receiving placebo in the same season, a difference that is not statistically significant (P40.05).
In season 3 , the height increment of children with respiratory infections o21.5% of the time (SE 3 RI 0 ) receiving vitamin A was 0.212 cm/4 months (ie, 0.330-0.118) higher (Po0.05) than that of their peers receiving placebo in the same season, while the height increment of children with respiratory infections Z21.5% of the time during season 3 (SE 3 RI 1 ) receiving vitamin A was only 0.194 cm/4 months (ie, 0.313-0.118) higher than that of their peers receiving placebo in the same season.
The weight increment was different by season (Table 4) . In season 1 , children with respiratory infections Z21.5% (SE 1 RI 1 ) gained about 0.545 kg/4 months. Children with respiratory infections o21.5% during season 1 (SE 1 RI 0 ) gained only 0.057 kg/4 months more in weight than children with respiratory infections Z21.5% (SE 1 RI 1 ) and the difference was not statistically significant. In season 2 , (SE 2 RI 0 and SE 2 RI 1 ) the average weight gain of children was about 0.180 kg/4 months more (Po0.05) than that in season 1 , while in season 3 (SE 3 RI 0 and SE 3 RI 1 ) it tended to be lower than that in season 1 regardless of the level of respiratory infections. Ponderal growth did not respond to vitamin A supplementation in this study population. There was no significant difference in weight increment between children receiving vitamin A and those receiving placebo regardless of the season and the burden of respiratory infections.
Effect of vitamin A on child growth by season, burden of respiratory infection and vitamin A intake
There was no significant difference in height increments between children stratified by combinations of season, burden of respiratory infections, and vitamin A intake (SERIVA), except for children with respiratory infections Z215%, and vitamin A intake 4400 RE/day in season 3 (SE 3 RI 1 VA 1 ) whose 4-month height increment was relatively higher than that of children from other groups (Figure 2) . However, the effect of vitamin A supplementation on linear growth was modified by SERIVA.
In season 1 (December-March), children with respiratory infections Z21.5% of the time and vitamin A intakes Z400 RE/ day (SE 1 RI 1 VA 1 ) receiving vitamin A gained 0.196 cm/4 months less in height than their peers receiving placebo (Figure 2 ), although the difference was not statistically significant (P40.05). Children with respiratory infections o21.5% of the observed time and vitamin A intakes o400 RE/day during season 1 (SE 1 RI 0 VA 0 ) receiving vitamin A, gained 0.404 cm/4 months more in height than children of SE 1 RI 1 VA 1 receiving vitamin A in the same season. In other words, the height increment of children of SE 1 RI 0 VA 0 receiving vitamin A was 0.208 cm/4 months (ie, 0.404-0.196) higher (Po0.05) than that of their peers receiving placebo in the same season. The height increment of children with respiratory infections o21.5% of the observed time but with vitamin A intakes Z400 RE/day during season 1 (SE 1 RI 0 VA 1 ) receiving vitamin A was only 0.028 cm/4 months higher (P40.05) than that of their peers receiving placebo in the same season. A similar difference in height increment (0.015 cm/4 months) between vitamin A and placebo groups was found in children with vitamin A intakes o400 RE/day but with respiratory infections Z21.5% of the observed time during season 1 (SE 1 RI 1 VA 0 ). 
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In season 2 (April-July), the height increment of children with respiratory infections o21.5% of the time and vitamin A intakes o400 RE/day (SE 2 RI 0 VA 0 ) receiving vitamin A was 0.161 cm/4 months more (P ¼ 0.050) than that of their peers receiving placebo in the same season. The height increment of children with respiratory infections o21.5% of the time and vitamin A intakes Z400 RE/day during season 2 (SE 2 R-I 0 VA 1 ) receiving vitamin A was 0.125 cm/4 months more (P ¼ 0.087) than that of their peers receiving placebo in the same season. The height increment of children with respiratory infections Z21.5% of the time but vitamin A intakes o400 RE/day during season 2 (SE 2 RI 1 VA 0 ) receiving vitamin A was 0.082 cm/4 months more (P ¼ 0.257) than that of their peers receiving placebo in the same season. In contrast, the height increment of children with respiratory infections Z21.5% of time and vitamin A intakes Z400 RE/ day during season 2 (SE 2 RI 1 VA 1 ) receiving vitamin A was only 0.015 cm/4 months more (P ¼ 0.333) than that of their peers receiving placebo in the same season.
In season 3 (August-November), the height increment of children with respiratory infections o21.5% of the time and vitamin A intakes o400 RE/day (SE 3 RI 0 VA 0 ) receiving vitamin A was 0.364 cm/4 month more (P ¼ 0.012) than that of their peers receiving placebo in the same season. The height increment of children with respiratory infections o21.5% of the time and vitamin A intakes Z400 RE/day during season 3 (SE 3 RI 0 VA 1 ) receiving vitamin A was 0.275 cm/4 month higher (P ¼ 0.001) than that of their peers receiving placebo in the same season. The height increment of children with respiratory infections Z21.5% but vitamin A intakes o400 RE/day during season 3 (SE 3 RI 1 VA 0 ) receiving vitamin A was 0.139 cm/4 month more (P ¼ 0.079) than that of their peers receiving placebo in the same season. In contrast, the height increment of children with respiratory infections Z21.5% of the time and vitamin A intakes Z400 RE/day during season 3 (SE 3 RI 1 VA 1 ) receiving vitamin A was 0.121 cm/4 month less than that of their peers receiving placebo in the same season, but the difference was not statistically significant (P ¼ 0.770).
Again, there was a significant difference in weight increment between seasons. The average weight increment during season 1 was 0.530 kg/4 month ( Table 5) . It was 0.171 kg/4 month to 0.218 kg/ 4 month higher (Po0.05) during season 2 and little bit lower during season 3 regardless of the burden of respiratory infections and vitamin A intakes. However, the ponderal growth response to vitamin A supplementation was not different by combination of season, burden of respiratory infections, and vitamin A intake.
Discussion
In this analysis, we found that the effect of vitamin A supplementation on linear growth could be observed in all seasons in children lacking a high burden of respiratory infection (ie, o21. 5% of the period under observation, representing the 75th percentile of illness burden). In each season, the strongest effect occurred in children with a lower burden of respiratory infection and a low vitamin A intake (ie, o400 RE/day). Children with a high burden of respiratory infection or high vitamin A intake benefited less from vitamin A supplementation with respect to linear growth.
Conversely, children suffering frequent respiratory infection and whose intake of vitamin A was above the normative requirement tended to exhibit a poorer linear growth response to vitamin A supplementation. These findings indicate that there were additive interactions between vitamin A supplementation, season, respiratory infections, and vitamin A intake.
A recent study has reported that the effect of vitamin A supplementation on the growth of preschool Indian children was limited to ponderal growth and only during the summer monsoon season (Bahl et al, 1997) . Vitamin A-supplemented preschool aged children in Nepal revealed a pattern of ponderal growth deceleration in the winter, more foodabundant season but gradually accelerated in weight gain throughout the dry and monsoon seasons, leaving a small net annual effect (West et al, 1997) . The mechanism behind this seasonal effect of vitamin A remains unclear. However, there are indications that seasonal variation in the burden of infectious diseases, especially respiratory infections and diarrhea, and seasonal availability of vitamin A-rich foods may mediate seasonal influences of vitamin A supplementation on growth.
We have reported that the effect of vitamin A supplementation on linear growth but not on ponderal growth of Indonesian preschoolers was strongest in the period of August-November in which the burden of ALRIs and diarrhea, as well as the vitamin A intake, were lowest (Hadi et al, 2002) . In this population, vitamin A supplementation exerted the least impact on linear growth between December and March, a time period in which both the burden of infectious diseases and the intakes of vitamin A were highest (Hadi et al, 2002) .
We have also previously reported that respiratory infections did not affect growth but did modify the effect of vitamin A supplementation on linear growth of preschool children. The effect was greatest in children with little or no burden of respiratory infection and virtually absent in children with a heavy burden of respiratory infections (Hadi et al, 1999) . Thus, in some populations it seems that respiratory infections may, in part, determine the seasonal effects of vitamin A supplementation on growth. With a high burden of respiratory infection, supplemental vitamin .8 with Pvalue ¼ 0.0000. The mean and standard error of mean are plotted for the following seasons, percent of days with ARI, and levels of vitamin A intake: SE 1 (December-March), SE 2 (April-July), and SE 3 (August-November); two levels of respiratory infections (RI 0 ¼ below or RI 1 ¼ above 21.5% of days with respiratory infections); and two levels of vitamin A intakes (VA 0 ¼ below or VA 1 ¼ above normative requirements, ie 400 RE/day).
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A may not be completely absorbed (Sivakumar & Reddy, 1972) and can be expected to be excreted in high quantity (Lawrie et al, 1941; Stephensen et al, 1994) . Alternatively, a lack of growth response to vitamin A may be due to nonspecific responses to fever during respiratory infections (Clausen & McCoord, 1938; Mendez et al, 1959) such that sufficient vitamin A is not available to improve growth. A significant effect of vitamin A supplementation was seen in all seasons among children with low or no burden of respiratory infections. Conversely, the effect was absent in children with a high burden of respiratory infection regardless of season.
We have reported that diarrhea affected the growth of preschool children but it did not modify the effect of vitamin A supplementation on growth (Hadi et al, 1999) Therefore, it is not reasonable to expect that diarrhea is one of the factors modifying the seasonal effect of vitamin A supplementation on growth. The lack of effect of vitamin A on ponderal growth but the presence of an effect on linear growth was probably due to the fact that vitamin A deficiency was not severe enough to be a growth-limiting factor in this population. Vitamin A supplementation does improve ponderal growth in severely vitamin A-deficient (Hadi et al, 2000) and xerophthalmic (West et al, 1997) children.
It is reasonable to expect that any growth response to vitamin A supplementation might be mediated by its effects on morbidity (Sommer & West, 1996) . However, in this study population, vitamin A supplementation had little effect on morbidity rates with no change in the incidence of diarrhea, but an 8% increase in the incidence of cough episodes (Dibley et al, 1996) . Since respiratory infection did not affect growth, there is no reason to relate the small increase in incidence due to vitamin A supplementation to poor growth. Thus, in this trial, the effect of vitamin A supplementation on growth appears to be independent from its effect on morbidity.
Adequate child growth is the result of highly complex nutritional, health, and genetic interactions that also determine the extent and duration of a growth response to a single nutrient intervention. The present findings underscore the possibility of biologically plausible growth re- sponses to vitamin A being discerned when other causal influences on child growth are adequately controlled. The observed responses reveal the potential for vitamin A to improve growth under varying conditions of season, diet, and morbidity and also help to explain why such incremental effects may not be seen within and between populations (Lie et al, 1993; Ramakrishnan et al, 1995) . While the present growth findings may not drive policy related to the use of vitamin A, they reveal interactive effects of the intervention of sufficient magnitude that complement the impact on morbidity and mortality. In summary, it is clear that the effect of vitamin A supplementation on growth varies by season, and that this may be explained to a large measure in some populations by the frequency and presumably severity of respiratory infections. Among children with a lower burden of respiratory infection, the threshold of which may be expected to vary by population, and especially in those with low vitamin A intake, a significant effect of vitamin A supplementation on growth may occur throughout the year. In children with a high burden of respiratory infections and especially in those with high vitamin A intake, vitamin A may exert no growth effect regardless of season. Vitamin A supplementation programs may lead to improved growth of children in populations where vitamin A deficiency is prevalent, but it may need to be accompanied by efforts to reduce or control respiratory infections in order to realize a growth effect.
